Quantitative Biosciences Institute: UCSF QBI and Icahn School of Medicine at Mount Sinai Scientists Report New Preclinical Data Published in Science on Potential Best-in-Class COVID-19 Anti-Viral Treatment: Plitidepsin
(1) First studies reported on antiviral drug effects against new variant mutant "U.K." strain of SARS-CoV-2 Plitidepsin shows potent anti-viral effect in preclinical models of original SARS-CoV-2 as well as the new mutant U.K. strain, and by inhibiting a key host protein, has the potential to have antiviral activity against other future mutations and viruses Drug targets the biologic pathway prospectively identified and published in Nature months ago from QBI research on SARS CoV-2 which elucidated host proteins and pathways that fuel the survival and virulence of the virus SAN FRANCISCO, ...
Source: finanznachrichten.de